IMRN Immuron Ltd: Business Value to Revenue

Official company branding of Immuron Inc (IMRN)

The price-to-sales ratio helps determine the asset's actual bottom, while the 141.76 metric reflects current dynamics. Immuron Limited (IMRN) automates the packaging of gastrointestinal drugs, reducing reliance on manual labor. An environmental approach mandates that the company use recyclable packaging and raw materials. Global distribution expansion through pharmacies optimizes fixed costs, creating positive operating leverage.

Immuron Ltd (IMRN): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/19/2026

IMRN (immuron.com.au): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental company valuation:IMRN (Immuron Inc)
Product sample of Immuron Limited

This indicator determines the ratio of the total enterprise value, adjusted for net debt, to the volume of generated revenue, reflecting the actual market price per unit of sales. Given Immuron Limited (IMRN) dependence on Asian supplies and patent risks, sharp fluctuations in the enterprise value-to-sales multiple signal a revaluation of assets relative to their operational resilience.